We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Immunodiagnostic Systems Holdings Plc | LSE:IDH | London | Ordinary Share | GB00B01YZ052 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 378.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
25/8/2010 08:02 | New vit D test developed... by axis shield | spacecake | |
30/7/2010 09:48 | growth company COULD have written a better piece of analysis ;) | dasv | |
30/7/2010 09:34 | Thanks for the link Ikos, but the article is a poor effort. We all know it COULD be a good time to take your money off the table, but what we want is a reasoned analysis. Are they up against strong opposition? Not in their specialty according to my reading. Are they likely to bomb in the US, or is the market their much smaller than we are led to believe? I don't think so but am receptive to any evidence. My problem over the moderately successful years has been selling too early but I really think this one has further to go. Sorry, COULD have further to go. | dozey1 | |
22/7/2010 13:00 | Interesting article. I particularly like this bit: '...and the staggering thing is that I just see more prospects going forward, it is awesome.' | pentangle | |
21/7/2010 18:48 | Thanks for the Link. | philo124 | |
21/7/2010 17:23 | When Roger Duggan brought his company to AIM in 2004, investors bought in at 51p per share. This month, stock in Immunodiagnostic Systems Hldgs (LON:IDH) was changing hands at 800p. For the company's chief executive, the "astonishing" upward trajectory has followed a period of dramatic change for the diagnostic testing specialist, which is currently embarking on a major new offensive to sell a new generation of immunoassay kits to even larger markets..... More here - | steadyitgoes | |
20/7/2010 10:36 | Actually, and being charitable, it may not be as bad as it looks on the surface as they have plenty of share options left. This includes the sales/marketing guy who seems to have sold his entire holding. I know he has at least another 50,000 of options at 263p awarded last year and probably more besides. I suppose they are entitled to enjoy the benefits of their success, but the fact that they are cashing in certainly, at best, does not suggest they expect the shares to go through the roof any time soon. | pentangle | |
20/7/2010 09:11 | Not unusual given the quantity sold/bought; it will be interesting who they let in, should see RNS before too long; maybe US investors. Puts floor price under shares IMO | philo124 | |
20/7/2010 08:44 | I like the sarcasm ... How can this be good news. If you owned shares and were asked to sell them for 725p, when they've been trading at 770-790p, why would you sell them. Unless, of course, you thought they were fully valued ... | theoriginalwonderstuff | |
20/7/2010 08:31 | Yep, this is usually good news. | philo124 | |
20/7/2010 07:13 | Nice vote of confidence from our Directors......... | pentangle | |
19/7/2010 16:52 | VOLUME OVER 4 MILLION, DESPITE 935P PRICE TARGET FROM 1 BROKER | philo124 | |
16/7/2010 22:55 | chart looking ready to pop could be a big move when it breaks | cat | |
16/7/2010 16:55 | GOOD CLOSE | philo124 | |
12/7/2010 10:57 | excellent results, revenue and profit growth. | dasv | |
12/7/2010 07:50 | Pretty good results on the face of it. | tday | |
03/7/2010 07:35 | The good US news has arrived quicker than I expected. Now the price looks to be making a little half-mast flag, implying about 900 as the next stop. | jon l | |
02/7/2010 15:14 | In Spain, just seen news! Bought last week; broker saya hold ontoseeif previoushigh cleared. Any thoughts. Same broker who was less than enthusiastic when i wanted to buy at 360p LOL! | philo124 | |
02/7/2010 11:51 | h28: suggest you research what IDS does before posting. | dasv | |
02/7/2010 11:24 | i would not touch any pharm company. electromedicine like this used on space programmes renders assays etc useless, expensive and not needed. my mate got malaria out of his system. many elisa blot tests etc are not needed, with weak govt talk is nhs trauma will be kept but this technology made public so that chronic and personal health is responsibility of individual. also some of the zappers are used for depression instead of prozac etc. pharm companies and drugs are expensive, with this they are worthless. | h28 | |
02/7/2010 11:21 | Call for questions for forthcoming IDH interview next week - You can post them on the site or email them to editorial@stockopedi | steadyitgoes | |
01/7/2010 10:53 | They have been tipped in newspapers "buy on weakness" Nice tree shake this morning... | nellie1973 | |
30/6/2010 13:27 | No problem dasv. | liarspoker |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions